Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Calcitonin salmon - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for calcitonin salmon and what is the scope of calcitonin salmon freedom to operate?

Calcitonin salmon
is the generic ingredient in four branded drugs marketed by Mylan Ireland Ltd, Sanofi Aventis Us, Par Pharm, Igi Labs Inc, Apotex Inc, and Upsher Smith, and is included in eight NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for calcitonin salmon. Six suppliers are listed for this compound.

Summary for Generic Name: calcitonin salmon

Tradenames:4
Patents:4
Applicants:6
NDAs:8
Drug Master File Entries: see list14
Suppliers / Packagers: see list6
Bulk Api Vendors: see list10
Clinical Trials: see list41
Patent Applications: see list4
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:calcitonin salmon at DailyMed

Pharmacology for Ingredient: calcitonin salmon

Ingredient-typeCalcitonin
Drug ClassCalcitonin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
CALCIMAR
calcitonin salmon
INJECTABLE;INJECTION017497-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
CALCIMAR
calcitonin salmon
INJECTABLE;INJECTION017769-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Apotex Inc
CALCITONIN-SALMON
calcitonin salmon
SPRAY, METERED;NASAL076396-001Nov 17, 2008ABRXNoYes► Subscribe► Subscribe
Mylan Ireland Ltd
MIACALCIN
calcitonin salmon
INJECTABLE;INJECTION017808-001Jul 3, 1986DISCNNoNo► Subscribe► Subscribe
Par Pharm
CALCITONIN-SALMON
calcitonin salmon
SPRAY, METERED;NASAL076979-001Jun 8, 2009ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot